Century Therapeutics
(NASDAQ) IPSC
Century Therapeutics Financials at a Glance
Market Cap
$413.36M
Revenue (TTM)
$109.16M
Net Income (TTM)
$9.58M
EPS (TTM)
$-0.11
P/E Ratio
-21.84
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.48
Volume
1,629,625.985
Open
$2.27
Price
$2.48
Volume
1,629,625.985
Open
$2.27
Previous Close
$2.49
Daily Range
$2.25 - $2.54
52-Week Range
$0.34 - $3.04
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$2.48
Volume
1,629,625.985
Open
$2.27
Previous Close
$2.49
Daily Range
$2.25 - $2.54
52-Week Range
$0.34 - $3.04
IPSC News
IPSC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Century Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
78
CEO
Brent Pfeiffenberger, PharmD
Website
www.centurytx.comHeadquarters
Philadelphia, PA 19104, US
IPSC Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-14%
Net Income Margin
-9%
Return on Equity
-6%
Return on Capital
-7%
Return on Assets
-4%
Earnings Yield
-4.58%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$413.36M
Shares Outstanding
179.72M
Volume
1.63M
Short Interest
0.00%
Avg. Volume
1.84M
Financials (TTM)
Gross Profit
$96.06M
Operating Income
$15.04M
EBITDA
$1.94M
Operating Cash Flow
$103.88M
Capital Expenditure
$848.00K
Free Cash Flow
$104.72M
Cash & ST Invst.
$117.11M
Total Debt
$43.56M
Century Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$3.55M
-185.1%
Gross Margin
0.00%
N/A
Market Cap
$413.36M
N/A
Market Cap/Employee
$2.95M
N/A
Employees
140
N/A
Net Income
$19.18M
+46.8%
EBITDA
$18.70M
+39.6%
Quarterly Fundamentals
Net Cash
$73.55M
-45.7%
Accounts Receivable
$667.00K
-56.1%
Inventory
$0.00
N/A
Long Term Debt
$40.24M
-17.8%
Short Term Debt
$3.32M
-31.7%
Return on Assets
-4.28%
N/A
Return on Invested Capital
-7.39%
N/A
Free Cash Flow
$16.39M
+32.7%
Operating Cash Flow
$16.08M
+33.6%